tiprankstipranks
Advertisement
Advertisement

GB:AZN Stock Latest News

AstraZeneca Earnings Call: Oncology Strength, Pipeline Bets
Company AnnouncementsAstraZeneca Earnings Call: Oncology Strength, Pipeline Bets
1d ago
AZN
FDA blocked publication of studies showing Covid vaccine safe, NYT says
PremiumThe Fly
FDA blocked publication of studies showing Covid vaccine safe, NYT says
1d ago
AZN
BMY
AstraZeneca Advances Early Liver-Function Trial That Could Shape Dosing for Future AZN Drugs
PremiumCompany Announcements
AstraZeneca Advances Early Liver-Function Trial That Could Shape Dosing for Future AZN Drugs
1d ago
AZN
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
PremiumThe Fly
Trump Trade: Microsoft, Google agree to U.S. security reviews of AI models
2d ago
AZN
BMY
AstraZeneca Updates Total Voting Rights and Admits New Shares from Employee Schemes
PremiumCompany Announcements
AstraZeneca Updates Total Voting Rights and Admits New Shares from Employee Schemes
6d ago
AZN
ODAC recommends AstraZeneca Truqap for hormone-sensitive prostate cancer
PremiumThe FlyODAC recommends AstraZeneca Truqap for hormone-sensitive prostate cancer
6d ago
AZN
FDA panel’s negative vote clouds AstraZeneca’s bid for camizestrant in advanced breast cancer
Premium
Company Announcements
FDA panel’s negative vote clouds AstraZeneca’s bid for camizestrant in advanced breast cancer
6d ago
AZN
FDA Panel Backs AstraZeneca’s Truqap Combo for Aggressive Prostate Cancer
Premium
Company Announcements
FDA Panel Backs AstraZeneca’s Truqap Combo for Aggressive Prostate Cancer
6d ago
AZN
AstraZeneca says FDA AdCom recommend Truqap in mHSPC
PremiumThe Fly
AstraZeneca says FDA AdCom recommend Truqap in mHSPC
6d ago
AZN
AstraZeneca to ‘continue to work with FDA’ after vote against camizestrant
PremiumThe Fly
AstraZeneca to ‘continue to work with FDA’ after vote against camizestrant
6d ago
AZN
AstraZeneca: Buy Rating Reiterated as Camizestrant Upside and 18,000p Target Offset ODAC Setback
PremiumRatings
AstraZeneca: Buy Rating Reiterated as Camizestrant Upside and 18,000p Target Offset ODAC Setback
6d ago
AZN
Jefferies says ODAC vote against AstraZeneca’s SERENA-6 not a surprise
PremiumThe Fly
Jefferies says ODAC vote against AstraZeneca’s SERENA-6 not a surprise
6d ago
AZN
FDA panel votes 6-3 to reject AstraZeneca breast cancer drug, Bloomberg says
PremiumThe FlyFDA panel votes 6-3 to reject AstraZeneca breast cancer drug, Bloomberg says
6d ago
AZN
Guardant falls after FDA panel votes down AstraZeneca breast cancer drug
Premium
The Fly
Guardant falls after FDA panel votes down AstraZeneca breast cancer drug
6d ago
GH
AZN
AstraZeneca upgraded to Buy from Hold at DZ Bank
Premium
The Fly
AstraZeneca upgraded to Buy from Hold at DZ Bank
7d ago
AZN
AstraZeneca reports Q1 core EPS $2.58, consensus $1.27
PremiumThe Fly
AstraZeneca reports Q1 core EPS $2.58, consensus $1.27
8d ago
AZN
AstraZeneca sees FY26 core EPS up low double-digit percentage
PremiumThe Fly
AstraZeneca sees FY26 core EPS up low double-digit percentage
8d ago
AZN
AstraZeneca posts strong Q1 2026 growth and doubles down on high-value pipeline
PremiumCompany Announcements
AstraZeneca posts strong Q1 2026 growth and doubles down on high-value pipeline
8d ago
AZN
Overhang should lift for Guardant after AstraZeneca AdCom, says Leerink
PremiumThe Fly
Overhang should lift for Guardant after AstraZeneca AdCom, says Leerink
8d ago
GH
AZN
Guardant falls after FDA briefing documents for camizestrant
PremiumThe FlyGuardant falls after FDA briefing documents for camizestrant
8d ago
GH
AZN
FDA turning to AI to speed up clinical trials, WSJ reports
Premium
The Fly
FDA turning to AI to speed up clinical trials, WSJ reports
8d ago
AZN
TEM
AstraZeneca’s Breztri approved in U.S. for maintenance treatment of asthma
Premium
The Fly
AstraZeneca’s Breztri approved in U.S. for maintenance treatment of asthma
9d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >